Eli Lilly, CFO Anat Ashkenazi on managing growing demand for LPG-1
A pharmacist holds boxes of Eli Lilly & Co. Mounjaro brand tirzepatide arranged at a pharmacy in Provo, Utah, U.S.,…
Eli Lilly and company
FDA advisors recommend donanemab, Eli Lilly's Alzheimer's drug
Eli Lilly headquarters in Indianapolis, Indiana, U.S., on Wednesday, May 3, 2023. Shares of Eli Lilly & Co. rose in…
AstraZeneca and drugmakers release promising cancer data
Attendees walk through the lobby of the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Half of Workers May Have Difficulty Obtaining Obesity Drug Insurance Coverage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Wells Fargo CEO Talks Reasons to Love Stocks, Plus Why the Market is Falling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Ro launches GLP-1 supply tracker to help patients overcome shortages
Zoom in iconArrows pointing outwards Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular…
Eli Lilly invests to increase Mounjaro and Zepbound offering
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
Eli Lilly and Novo Nordisk develop weekly insulin
A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | fake images Do you think a friend…